{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T16:39:05Z","timestamp":1770741545680,"version":"3.49.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medicina de Familia. SEMERGEN"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.semerg.2020.02.001","type":"journal-article","created":{"date-parts":[[2020,3,28]],"date-time":"2020-03-28T08:28:56Z","timestamp":1585384136000},"page":"392-399","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Why are antithrombotic drugs not prescribed to octogenarian patients with atrial fibrillation at risk of stroke?"],"prefix":"10.1016","volume":"46","author":[{"given":"F.","family":"Formiga","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Polo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Fern\u00e1ndez de Cabo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Arum\u00ed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.semerg.2020.02.001_bib0135","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.medcli.2011.05.023","article-title":"Prevalencia de la fibrilaci\u00f3n auricular y factores relacionados en pacientes ancianos hospitalizados: estudio ESFINGE","volume":"138","author":"L\u00f3pez Soto","year":"2012","journal-title":"Med Cl\u00edn"},{"key":"10.1016\/j.semerg.2020.02.001_bib0140","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1161\/01.STR.0000230607.07928.17","article-title":"Atrial fibrillation and stroke in the general medicare population: a 10-year perspective (1992 to 2002)","volume":"37","author":"Lakshminarayan","year":"2006","journal-title":"Stroke"},{"key":"10.1016\/j.semerg.2020.02.001_bib0145","first-page":"e391","article-title":"Epidemiology of stroke in Europe and trends for the 21st century","volume":"45","author":"B\u00e9jot","year":"2016","journal-title":"Press Med Paris Fr 1983"},{"key":"10.1016\/j.semerg.2020.02.001_bib0150","first-page":"15","article-title":"Antithrombotic treatment in elderly patients with atrial fibrillation: a practical approach","author":"Su\u00e1rez Fern\u00e1ndez","year":"2015","journal-title":"BMC Cardiovasc Disord [Internet]"},{"key":"10.1016\/j.semerg.2020.02.001_bib0155","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1093\/eurheartj\/ehw210","article-title":"2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS","volume":"37","author":"Kirchhof","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.semerg.2020.02.001_bib0160","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.amjmed.2009.11.025","article-title":"Underuse of oral anticoagulants in atrial fibrillation: a systematic review","volume":"123","author":"Ogilvie","year":"2010","journal-title":"Am J Med"},{"key":"10.1016\/j.semerg.2020.02.001_bib0165","article-title":"A survey on the awareness and attitude of physicians on direct oral anticoagulants in Qatar","author":"El-Bardissy","year":"2018","journal-title":"Clin Appl Thromb Off J Int Acad Clin Appl Thromb"},{"key":"10.1016\/j.semerg.2020.02.001_bib0170","doi-asserted-by":"crossref","first-page":"A490","DOI":"10.1016\/S0735-1097(18)31031-3","article-title":"Cost effectiveness of oral anticoagulation therapy for non-valvular atrial fibrillation patients: warfarin versus the new oral anticoagulants rivaroxaban, dabigatran and apixaban","volume":"71","author":"Ortiz-Cartagena","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.semerg.2020.02.001_bib0175","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1093\/ageing\/afr097","article-title":"Attitudes of physicians regarding anticoagulation for atrial fibrillation: a systematic review","volume":"40","author":"Pugh","year":"2011","journal-title":"Age Age"},{"key":"10.1016\/j.semerg.2020.02.001_bib0180","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1111\/jgs.15058","article-title":"Effect of new oral anticoagulants on prescribing practices for atrial fibrillation in older adults","volume":"65","author":"Fohtung","year":"2017","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.semerg.2020.02.001_bib0185","article-title":"Profiling of patients with non-valvular atrial fibrillation and moderate-to-high risk of stroke not receiving oral anticoagulation in Spain","author":"Polo Garc\u00eda","year":"2018","journal-title":"Med Fam SEMERGEN [Internet]"},{"key":"10.1016\/j.semerg.2020.02.001_bib0190","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1001\/jama.285.22.2864","article-title":"Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation","volume":"285","author":"Gage","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.semerg.2020.02.001_bib0195","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1378\/chest.09-1584","article-title":"Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach","volume":"137","author":"Lip","year":"2010","journal-title":"Chest"},{"key":"10.1016\/j.semerg.2020.02.001_bib0200","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1378\/chest.10-0134","article-title":"A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation","volume":"138","author":"Pisters","year":"2010","journal-title":"Chest"},{"key":"10.1016\/j.semerg.2020.02.001_bib0205","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1176\/ajp.139.9.1136","article-title":"The Global Deterioration Scale for assessment of primary degenerative dementia","volume":"139","author":"Reisberg","year":"1982","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.semerg.2020.02.001_bib0210","first-page":"61","article-title":"Functional evaluation: the Barthel Index","volume":"14","author":"Mahoney","year":"1965","journal-title":"Md State Med J"},{"key":"10.1016\/j.semerg.2020.02.001_bib0215","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.ijcard.2017.01.046","article-title":"Oral anticoagulant use in octogenarian European patients with atrial fibrillation: a subanalysis of PREFER in AF","volume":"232","author":"Hanon","year":"2017","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.semerg.2020.02.001_bib0220","first-page":"169","article-title":"The effect of bleeding risk and frailty status on anticoagulation patterns in octogenarians with atrial fibrillation: the FRAIL-AF study","volume":"32","author":"Lefebvre","year":"2016","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.semerg.2020.02.001_bib0225","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ijcard.2016.08.004","article-title":"Oral anticoagulation in octogenarians with atrial fibrillation","volume":"223","author":"Hugo","year":"2016","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.semerg.2020.02.001_bib0230","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/jgs.13200","article-title":"Underuse of oral anticoagulation for individuals with atrial fibrillation in a nursing home setting in france: comparisons of resident characteristics and physician attitude","volume":"63","author":"Bahri","year":"2015","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.semerg.2020.02.001_bib0235","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.recesp.2013.03.006","article-title":"Prevalence of undiagnosed atrial fibrillation and of that not being treated with anticoagulant drugs: the AFABE study","volume":"66","author":"Clua-Espuny","year":"2013","journal-title":"Rev Esp Cardiol Engl Ed"},{"key":"10.1016\/j.semerg.2020.02.001_bib0240","doi-asserted-by":"crossref","first-page":"3477","DOI":"10.1161\/STROKEAHA.111.625392","article-title":"Antithrombotic therapy use at discharge and 1 year in patients with atrial fibrillation and acute stroke: results from the AVAIL registry","volume":"42","author":"Lopes","year":"2011","journal-title":"Stroke"},{"key":"10.1016\/j.semerg.2020.02.001_bib0245","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ejim.2017.03.012","article-title":"Oral anticoagulant therapy for older patients with atrial fibrillation: a review of current evidence","volume":"41","author":"Bo","year":"2017","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.semerg.2020.02.001_bib0250","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1001\/archinte.159.7.677","article-title":"Choosing antithrombotic therapy for elderly patients with atrial fibrillation who are at risk for falls","volume":"159","author":"Man-Son-Hing","year":"1999","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.semerg.2020.02.001_bib0255","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/jgs.14573","article-title":"Continued use of warfarin in veterans with atrial fibrillation after dementia diagnosis","volume":"65","author":"Orkaby","year":"2017","journal-title":"J Am Geriatr Soc"}],"container-title":["Medicina de Familia. SEMERGEN"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1138359320300563?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1138359320300563?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T04:39:51Z","timestamp":1761107991000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1138359320300563"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":25,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["S1138359320300563"],"URL":"https:\/\/doi.org\/10.1016\/j.semerg.2020.02.001","relation":{},"ISSN":["1138-3593"],"issn-type":[{"value":"1138-3593","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Why are antithrombotic drugs not prescribed to octogenarian patients with atrial fibrillation at risk of stroke?","name":"articletitle","label":"Article Title"},{"value":"Medicina de Familia. SEMERGEN","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semerg.2020.02.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Sociedad Espa\u00f1ola de M\u00e9dicos de Atenci\u00f3n Primaria (SEMERGEN). Published by Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}